Hormones part 2: Insulin and other glucose-controlling medications

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Diabetes mellitus (DM) is an extremely common disease process worldwide. Diabetic patients often need surgical interventions for a wide variety of reasons. One of the differences between type 1 and type 2 DM is that patients with type 1 would die without insulin and is associated with an autoimmune attack on the patient’s beta cells in the pancreas. Type II diabetes mellitus (T2DM) is characterized by insulin deficiency, insulin resistance, and increased hepatic glucose output. The chronic state of elevated glucose levels affects the whole body at a macro- and microvascular level, ultimately leading to the deterioration of vital organs, such as the kidney, cardiac, and nervous system. Diabetes is the leading cause of renal insufficiency in the United States and is a strong risk factor for coronary artery disease. This chronic state affects many perioperative patients currently, and its prevalence is projected to increase substantially in the near future.

Original languageEnglish (US)
Title of host publicationEssentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care
PublisherSpringer New York
Pages327-343
Number of pages17
ISBN (Print)9781461489481, 9781461489474
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hormones
Insulin
Glucose
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Nervous System
Renal Insufficiency
Insulin Resistance
Coronary Artery Disease
Pancreas
Diabetes Mellitus
Kidney
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vivek, K., Reddy, S. G., & Gonzalez, J. (2015). Hormones part 2: Insulin and other glucose-controlling medications. In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care (pp. 327-343). Springer New York. https://doi.org/10.1007/978-1-4614-8948-1_20

Hormones part 2 : Insulin and other glucose-controlling medications. / Vivek, Kumar; Reddy, Shamantha G.; Gonzalez, Justo.

Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2015. p. 327-343.

Research output: Chapter in Book/Report/Conference proceedingChapter

Vivek, K, Reddy, SG & Gonzalez, J 2015, Hormones part 2: Insulin and other glucose-controlling medications. in Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, pp. 327-343. https://doi.org/10.1007/978-1-4614-8948-1_20
Vivek K, Reddy SG, Gonzalez J. Hormones part 2: Insulin and other glucose-controlling medications. In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York. 2015. p. 327-343 https://doi.org/10.1007/978-1-4614-8948-1_20
Vivek, Kumar ; Reddy, Shamantha G. ; Gonzalez, Justo. / Hormones part 2 : Insulin and other glucose-controlling medications. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2015. pp. 327-343
@inbook{9834375f45804372b4a842c295ab28e2,
title = "Hormones part 2: Insulin and other glucose-controlling medications",
abstract = "Diabetes mellitus (DM) is an extremely common disease process worldwide. Diabetic patients often need surgical interventions for a wide variety of reasons. One of the differences between type 1 and type 2 DM is that patients with type 1 would die without insulin and is associated with an autoimmune attack on the patient’s beta cells in the pancreas. Type II diabetes mellitus (T2DM) is characterized by insulin deficiency, insulin resistance, and increased hepatic glucose output. The chronic state of elevated glucose levels affects the whole body at a macro- and microvascular level, ultimately leading to the deterioration of vital organs, such as the kidney, cardiac, and nervous system. Diabetes is the leading cause of renal insufficiency in the United States and is a strong risk factor for coronary artery disease. This chronic state affects many perioperative patients currently, and its prevalence is projected to increase substantially in the near future.",
author = "Kumar Vivek and Reddy, {Shamantha G.} and Justo Gonzalez",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-8948-1_20",
language = "English (US)",
isbn = "9781461489481",
pages = "327--343",
booktitle = "Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care",
publisher = "Springer New York",

}

TY - CHAP

T1 - Hormones part 2

T2 - Insulin and other glucose-controlling medications

AU - Vivek, Kumar

AU - Reddy, Shamantha G.

AU - Gonzalez, Justo

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Diabetes mellitus (DM) is an extremely common disease process worldwide. Diabetic patients often need surgical interventions for a wide variety of reasons. One of the differences between type 1 and type 2 DM is that patients with type 1 would die without insulin and is associated with an autoimmune attack on the patient’s beta cells in the pancreas. Type II diabetes mellitus (T2DM) is characterized by insulin deficiency, insulin resistance, and increased hepatic glucose output. The chronic state of elevated glucose levels affects the whole body at a macro- and microvascular level, ultimately leading to the deterioration of vital organs, such as the kidney, cardiac, and nervous system. Diabetes is the leading cause of renal insufficiency in the United States and is a strong risk factor for coronary artery disease. This chronic state affects many perioperative patients currently, and its prevalence is projected to increase substantially in the near future.

AB - Diabetes mellitus (DM) is an extremely common disease process worldwide. Diabetic patients often need surgical interventions for a wide variety of reasons. One of the differences between type 1 and type 2 DM is that patients with type 1 would die without insulin and is associated with an autoimmune attack on the patient’s beta cells in the pancreas. Type II diabetes mellitus (T2DM) is characterized by insulin deficiency, insulin resistance, and increased hepatic glucose output. The chronic state of elevated glucose levels affects the whole body at a macro- and microvascular level, ultimately leading to the deterioration of vital organs, such as the kidney, cardiac, and nervous system. Diabetes is the leading cause of renal insufficiency in the United States and is a strong risk factor for coronary artery disease. This chronic state affects many perioperative patients currently, and its prevalence is projected to increase substantially in the near future.

UR - http://www.scopus.com/inward/record.url?scp=84944543036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944543036&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8948-1_20

DO - 10.1007/978-1-4614-8948-1_20

M3 - Chapter

AN - SCOPUS:84944543036

SN - 9781461489481

SN - 9781461489474

SP - 327

EP - 343

BT - Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care

PB - Springer New York

ER -